Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

GUÍAS CLÍNICAS


15 mayo 2008

CIRCULATION. Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Writing Committee Members: Andrew E. Epstein, John P. DiMarco, Kenneth A. Ellenbogen, N.A. Mark Estes III, Roger A. Freedman, Leonard S. Gettes, A. Marc Gillinov, Gabriel Gregoratos, Stephen C. Hammill, David L. Hayes, Mark A. Hlatky, L. Kristin Newby, Richard L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson and Michael O. Sweeney

Copyright © 2008 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539

27 mayo 2009

NICE. Guidance for percutaneous laser revascularisation for refractory angina pectoris

NICE Guidance

Current evidence on percutaneous laser revascularisation (PLR) for refractory angina pectoris shows no efficacy and suggests that the procedure may pose unacceptable safety risks. Therefore, this procedure should not be used. Interventional procedure guidance 302. Copyright © National Institute for Health and Clinical Excellence, 2009. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

28 octubre 2009

NICE. Guidance for percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia

NICE Guidance

The evidence on percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia (VT) is limited to a small number of patients, but it shows that the procedure is efficacious in carefully selected individuals and raises no major safety issues, in the context of a condition which is potentially life-threatening. Therefore, the procedure may be used with normal arrangements for clinical governance, but with special arrangements for consent. Interventional procedure guidance 295. Copyright © National Institute for Health and Clinical Excellence, 2009. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

28 octubre 2009

NICE. Guidance for percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation

NICE Guidance

Current evidence on the safety and efficacy of percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation (AF) is inadequate in quantity. Therefore this procedure should only be used with special arrangements for clinical governance and consent. Interventional procedure guidance 294. Copyright © National Institute for Health and Clinical Excellence, 2009. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of NICE.

28 noviembre 2007

NICE. Guidance for percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction

NICE Guidance

The evidence on percutaneous pulmonary valve implantation for right ventricular outflow tract (RVOT) dysfunction is limited to small numbers of patients but shows good short-term efficacy. There is little evidence on long-term efficacy. There are no particular safety concerns in the context of a condition that otherwise requires open cardiac surgery. Clinicians wishing to use this procedure should do so only with special arrangements for clinical governance, consent and for audit or research. Interventional procedure guidance 237. Copyright © National Institute for Health and Clinical Excellence, 2007. All rights reserved. This material may be freely reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the express written permission of the Institute.

08 noviembre 2011

CIRCULATION. Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy.

Writing Committee Members: Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson and Clyde W. Yancy.

Copyright © 2011 American Heart Association. All rights reserved. Print ISSN: 0009-7322. Online ISSN: 1524-4539

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.